Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS)

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 8, 2009, Pages 778-779

  Tzakas, E ^a   Liu, S ^b   Todd, R W ^a   Redman, C W ^a  

^a CITY GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LETROZOLE; MEGESTROL ACETATE;

ADULT; ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER STAGING; CASE REPORT; DRUG WITHDRAWAL; ENDOMETRIUM SARCOMA; ERYTHEMA; FEMALE; HUMAN; LAPAROSCOPY; MACULOPAPULAR RASH; PRIORITY JOURNAL; PRURITUS; RECURRENT CANCER; SKIN ALLERGY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; VAGINA DISCHARGE;

ANTINEOPLASTIC AGENTS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NITRILES; SARCOMA, ENDOMETRIAL STROMAL; TREATMENT OUTCOME; TRIAZOLES;

EID: 70350088208     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443610903165552     Document Type: Article

References (13)

1. Chu MC, Mor G, Lim C, et al. 2003. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecologic Oncology 90:170-176.
2. De Fusco PA, Gaffey TA, Malkasian GD, et al. 1989. Endometrial stromal sarcoma: review of the mayo Clinic experience, 1945- 1980. Gynecologic Oncology 35:8-14.
3. Evans HL. 1982. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50:2170-2182.
4. Krauss K, Bachmann C, Hartmann JT, et al. 2007. Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole. Anticancer Research 27:3477-3480.
5. Leunen M, Breugelmans M, De Sutter P, et al. 2004. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecologic Oncology 95:769-771.
6. Maluf FC, Sabbatini P, Schwartz L, et al. 2001. Endometrial stromal sarcoma: objective response to letrozole. Gynecologic Oncology 82:384-388.
7. Nordal RR, Kristensen GB, Kaern J, et al. 1996. The prognostic significance of surgery, tumour size, malignancy grade, menopausal status and DNA ploidy in endometrial stromal sarcoma. Gynecologic Oncology 62:254-259.
8. Olah KS, Gee H, Blunt S, et al. 1991. Retrospective analysis of 318 cases of uterine sarcoma. European Journal of Cancer 27:1095-1099.
9. Piver MS, Rutledge FN, Copeland L, et al. 1995. Uterine endolymphatic stromal myosis: a collaborative study. Obstetrics and Gynecology 64:173.
10. Pink D, Lindner T, Mrozek A, et al. 2006. Harm or benefit of hormonal treatment in metastatic low grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecologic Oncology 101:464-469.
11. Reich O, Regauer S. 2007. Hormonal therapy of endometrial stromal sarcoma. Current Opinion in Oncology 19:347-352.
12. Sabini G, Chumas JC, Mann WJ. 1992. Steroid hormone receptors in endometrial stromal sarcomas: a biochemical and immunohistochemical study. American Journal of Clinical Pathology 97:381-386.
13. Spano JP, Soria JC, Kambouchner M, et al. 2003. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Medical Oncology 20:87-93.